ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company (LJPC)

6,23
0,00
(0,00%)
Beim Schlusskurs: 01 November 9:00PM
6,23
0,00
( 0,00% )
Nach Börsenschluss: -

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
6,23
Gebot
6,54
Fragen
6,25
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
6,23
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

LJPC Neueste Nachrichten

Innoviva Completes Acquisition of La Jolla Pharmaceutical

Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender...

Innoviva to Acquire La Jolla Pharmaceutical Company

Acquisition to strengthen Innoviva’s infectious disease and hospital portfolio with addition of GIAPREZA® and XERAVA® Innoviva, Inc. (Nasdaq: INVA), a diversified holding company with a...

La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases...

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Corporate Progress

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases...

La Jolla Pharmaceutical Company Announces Share Repurchase Plan

La Jolla Pharmaceutical Company (Nasdaq: LJPC) today announced that it will commence a share repurchase plan for up to $10 million of the Company’s common stock. Repurchases may be made from time...

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases...

Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases...

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases...

La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 & Highlights Corporate ...

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from...

La Jolla Pharmaceutical Company Announces Financial Results for the Three & Twelve Months Ended December 31, 2020 & Highlight...

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
VSMEVS Media Holdings Ltd
US$ 1,72
(56,36%)
553,87k
PDEXProDex Inc
US$ 43,50
(40,23%)
25,13k
ICCTiCoreConnect Inc
US$ 0,207
(30,19%)
201,03k
ATHAAthira Pharma Inc
US$ 0,5466
(27,68%)
5,81M
PEVPhoenix Motor Inc
US$ 0,562
(23,65%)
3,87M
ELABElevai Labs Inc
US$ 0,045
(-23,73%)
15,37M
MMVMultiMetaVerse Holdings Ltd
US$ 0,3349
(-20,45%)
415,44k
ASURAsure Software Inc
US$ 8,00
(-19,35%)
11,84k
ARBEArbe Robotics Ltd
US$ 1,47
(-19,23%)
50,67k
OSTOstin Technology Group Company Ltd
US$ 0,4106
(-17,88%)
155,04k
INTCIntel Corporation
US$ 23,08
(7,25%)
31,95M
AMZNAmazon.com Inc
US$ 196,59
(5,47%)
19,76M
SVMHSRIVARU Holding Ltd
US$ 0,0314
(2,28%)
15,44M
ELABElevai Labs Inc
US$ 0,045
(-23,73%)
15,37M
AAPLApple Inc
US$ 222,268
(-1,61%)
8,2M

Kürzlich von Ihnen besucht

Delayed Upgrade Clock